Search Results

Electronic Sphygmomanometer (Model JN-163EW) is a home use digital monitor intended for use in measuring blood pressure in adult patient population with wrist circumference ranging from 13.5 cm to 19.5 cm.
The device is not intended to be a diagnostic device. Contact your physician if hypertensive values are indicated.

Electronic Sphygmomanometer is designed to measure the systolic and diastolic blood pressure of an individual by using a non-invasive technique in which an inflatable cuff is wrapped around the wrist. This is a home use device.
Measurement method to define systolic and diastolic pressure is similar to the Oscillometric method but uses an electronic pressure sensor rather than a stethoscope and mercury manometer. With a sensor, the microprocessor converts tiny alterations in cuff pressure to electrical signals and analyzes those signals to define the systolic and diastolic blood pressure and calculates heartbeat rate, which is a well-known technique in the market called the "Oscillometric method".
The electronic sphygmomanometer achieves its function by a software. As the hardware includes an LCD, it can show the results of the blood pressure measurements and store 99 groups of data which can be checked and deleted.
The device is composed of a main unit and a cuff unit. The cuff unit, which is applicable to wrist circumference approximately between 13.5 and 19.5 cm, includes the inflatable bladder and shell. The main unit consists of the microprocessor, pressure sensor, pump, the electromagnetic deflation control valve and the battery. The subject device is powered by 2X AAA Lithium battery.

The provided document describes the 510(k) submission for the Electronic Sphygmomanometer (Model JN-163EW). This submission demonstrates the device's substantial equivalence to a predicate device and includes information about performance testing, including clinical trials.

However, the document does not provide the detailed acceptance criteria and a study that proves the device meets those criteria in the format requested. Specifically, it lacks:

• A table of specific quantitative acceptance criteria for blood pressure measurement accuracy (e.g., mean absolute difference, standard deviation) and the corresponding reported performance values for the subject device.
• Detailed information about the sample size, data provenance, ground truth establishment, expert qualifications, and adjudication methods for the clinical study.
• Information about MRMC studies or independent standalone algorithm performance.

The document states that clinical trials were performed according to ISO 81060-2:2019+A1:2020, Non-Invasive Sphygmomanometers - Part 2: Clinical Validation of Automated Measurement Type. This standard defines the methodology for clinically validating automated sphygmomanometers, including acceptance criteria. While the submission states that "relevant volunteers were collected to conduct actual clinical trial of blood pressure measurement," it does not present the results of this clinical trial against the acceptance criteria outlined in the standard.

Therefore, I cannot fully answer the request based on the provided text, as the specific performance data against defined acceptance criteria is missing. I can, however, extract what information is present regarding the clinical study and identify what is missing.

Based on the provided text, here is what can be inferred and what is explicitly missing regarding the acceptance criteria and study:

1. A table of acceptance criteria and the reported device performance:

• Acceptance Criteria: Not explicitly stated in a table. However, the document mentions that "The clinical trials for the Electronic Sphygmomanometers were performed according to the standard ISO 81060-2:2019+A1:2020." This ISO standard defines specific accuracy requirements for automated sphygmomanometers. For example, ISO 81060-2 typically requires:
  • Mean difference between the device and reference method to be within ±5 mmHg.
  • Standard deviation of the difference to be within 8 mmHg.
  • Specific percentages of measurements falling within ±5 mmHg, ±10 mmHg, and ±15 mmHg.
  • These apply to both systolic and diastolic blood pressure.
• Reported Device Performance: NOT PROVIDED IN THE DOCUMENT. The document states that performance testing was carried out and that the device meets "performance specifications for its intended use" and that "clinical tests" demonstrate effectiveness, but it does not provide the numerical results (e.g., mean difference, standard deviation) from the clinical study that would demonstrate it met the ISO 81060-2 criteria.

2. Sample size used for the test set and the data provenance:

• Sample Size: The document only states "relevant volunteers were collected." The specific number required by ISO 81060-2 is typically at least 85 subjects with sufficient blood pressure distribution across different ranges (hypertensive, normotensive, hypotensive). The document does not specify the actual number of subjects used in this study.
• Data Provenance: Not explicitly stated. Likely collected prospectively as it refers to "actual clinical trial." The country of origin of the data is not specified, but given the manufacturer is in China, it's plausible the study was conducted there.

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:

• Ground Truth Establishment: The ISO 81060-2 standard requires ground truth for blood pressure measurements to be established by two or more trained observers using a reference sphygmomanometer (e.g., mercury or an accepted equivalent).
• Number and Qualifications of Experts: The document does not specify the number of experts or their qualifications (e.g., trained clinicians, physicians) used for establishing the ground truth in this particular study.

4. Adjudication method for the test set:

• Adjudication Method: ISO 81060-2 typically involves multiple observers taking simultaneous measurements on the same subject. The standard specifies how the readings from these observers are to be handled (e.g., averaging of simultaneous readings from two independent observers, with a third observer if there's a significant discrepancy). The document does not explicitly state the adjudication method used, beyond the general reference to adherence to ISO 81060-2.

5. If a multi reader multi case (MRMC) comparative effectiveness study was done, if so, what was the effect size of how much human readers improve with AI vs without AI assistance:

• Not Applicable. This device is an Electronic Sphygmomanometer, which directly measures blood pressure. It is not an AI-based diagnostic imaging device that assists human readers. Therefore, an MRMC study comparing human reader performance with and without AI assistance is not relevant to this device.

6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done:

• This device is a standalone automated device. Its "algorithm" is the oscillometric method embedded in the device to calculate blood pressure. The clinical validation per ISO 81060-2 is effectively a standalone performance test, comparing the device's readings to standard reference measurements performed by human observers.

7. The type of ground truth used:

• The ground truth for blood pressure measurement, as per ISO 81060-2, is typically established through simultaneous auscultatory measurements performed by trained human observers using a reference sphygmomanometer (e.g., mercury or appropriately calibrated aneroid/electronic device). This is a highly controlled clinical measurement.

8. The sample size for the training set:

• Not Applicable/Not Provided. Electronic sphygmomanometers using the oscillometric method are based on established biophysical principles and do not typically involve a "training set" in the machine learning sense. Their internal algorithms are generally fixed based on these principles and extensive engineering validation, rather than being "trained" on a large dataset of patient measurements to learn patterns. If any internal parameters were optimized, the document does not mention it or the size of such a dataset.

9. How the ground truth for the training set was established:

• Not Applicable/Not Provided, for the same reasons as point 8.

Ask a specific question about this device